Monday, July 25, 2016 at 12 – 1 pm Eastern
Watch the webinar recording below
Justin Gallivan, Program Manager-Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA). View bio (view slides)
Dr. Justin Gallivan joined the Defense Advanced Research Projects Agency in January 2014. He is interested in many facets of synthetic biology, including engineering microbial communities to produce small molecules or to prevent disease, and reprogramming multicellular organisms to perform complex tasks. Dr. Gallivan came to DARPA from Emory University, where he was an Associate Professor and a Winship Distinguished Research Professor in the Department of Chemistry. At Emory, he led a research program in RNA-based synthetic biology. Dr. Gallivan received a Bachelor of Science in Chemistry from the University of Illinois at Urbana-Champaign (1994) and a Doctor of Philosophy in Chemistry from the California Institute of Technology (2000), where he later completed a National Institutes of Health National Research Service Award postdoctoral fellowship. He has been a Fellow of the Alfred P. Sloan Foundation, a Camille Dreyfus Teacher-Scholar, a Beckman Young Investigator and a PopTech Science and Public Leadership Fellow.
John Julias, Program Manager Smart Collection, Intelligence Advanced Research Projects Activity (IARPA). View bio (view slides)
Dr. John Julias joined the Smart Collection Office at the Intelligence Advanced Research Projects Activity (IARPA) in December 2015. John’s research areas of interest include synthetic biology, emerging biological threats, and weapons of mass destruction.
Prior to coming to IARPA, John was a Program Manager in the Chem Bio Defense Division of the Homeland Security Advanced Research Projects Agency (HSARPA) in the Directorate of Science and Technology of the Department of Homeland Security. While at DHS, John managed programs in the areas of biosurveillance and pathogen characterization. From 2010-2014, Dr. Julias was a program manager at the Defense Advanced Research Projects Agency (DARPA) where he managed a diverse portfolio of research and development programs in the Strategic Technology Office and the Defense Sciences Office. The efforts included the development of technologies for intrinsic biocontainment, vaccine design and production, predicting pathogen evolution, and chemical collection and analysis. For his efforts on counter-pathogen technologies, he was the recipient of the SEC DEF Medal for Outstanding Public Service. Prior to joining DARPA, Dr. Julias was a science and technology consultant with Booz Allen Hamilton supporting clients at the Department of Defense as well as in the non-profit, global health area. Previously, he was a scientist at the National Cancer Institute-Frederick where he performed research on viral replication and drug resistance. Dr. Julias received a Ph.D. from the Department of Biochemistry at the West Virginia University School of Medicine (1997) and a Bachelor of Arts in Chemistry from Vanderbilt University (1991).
The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.